(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.data-privacy-src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-1666707-3', 'auto'); ga('send', 'pageview');


All European Marketing Authorisation Holders are concerned by Nitrosamine Regulatory Actions

There is serious workload expected from all marketing authorisation holders (MAH) in EU! Let’s see what is expected for MAH compliance related to nitrosamines. On 26 September 2019, the EMA

By |2020-03-26T12:32:54+01:00November 26th, 2019|FarmavitaR+ News|0 Comments

4th Annual Global Clinical Trials Connect 2020

The 4th Annual Global Clinical Trials Connect 2020 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical

By |2020-02-24T11:06:50+01:00November 8th, 2019|Events & Conferences|0 Comments